Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia.
The myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic disorders predominantly affecting the elderly. Patients frequently develop acute leukemia, but the majority suffer from the consequences of bone marrow failure. The underlying acquired genetic abnormality is the inadequate production of dysplastic and poorly functional cells resulting from defective differentiation and premature cell death of the abnormal hematopoietic clone. Although the pathogenesis is unknown, recent evidence suggests that a sequence of DNA lesions leads to alteration of the cellular function, emergence and consequent evolution of the premalignant clone.
Yoshida
Y
Y
Department of Medicine, Faculty of Medicine, Kyoto University, Japan.
Stephenson
J
J
Mufti
G J
GJ
D006801:Humans; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000473:pathology / Q000503:physiopathology; D011379:Prognosis